Definition

  • The urea cycle:
    • Is the sole source of endogenous production of arginine, ornithine, and citrulline;
    • Is the principal mechanism for the clearance of waste nitrogen resulting from protein turnover;
    • Is the principal mechanism for the metabolism of other nitrogenous metabolic compounds such as adenosine monophosphate;
    • Includes enzymes that overlap with the nitric oxide production pathway (ASS1 and ASL).

    The urea cycle comprises the following components:

    • Five catalytic enzymes:
      • Carbamoylphosphate synthetase I (CPS1)
      • Ornithine transcarbamylase (OTC)
      • Argininosuccinic acid synthetase (ASS1)
      • Argininosuccinic acid lyase (ASL)
      • Arginase (ARG1)

      Clinical Characteristics of Urea Cycle Disorders (UCDs)

      • N-acetyl glutamate synthetase (NAGS)

      Clinical Characteristics of Urea Cycle Disorders

      • Ornithine translocase (ORNT1; ornithine/citrulline carrier; solute carrier family 25, member 15)
      • Citrin (aspartate/glutamate carrier; solute carrier family 25, member 13)

      Severe Urea Cycle Defects (Neonatal Onset)

      • Urea cycle disorders (UCDs) result from inherited deficiencies in any one of the six enzymes or two transporters of the urea cycle pathway, specifically:
        • CPS1 (Carbamoylphosphate synthetase I)
        • OTC (Ornithine transcarbamylase)
        • ASS1 (Argininosuccinic acid synthetase)
        • ASL (Argininosuccinic acid lyase)
        • ARG1 (Arginase)
        • NAGS (N-acetyl glutamate synthetase)
        • ORNT1 (Ornithine translocase)
        • Citrin (Aspartate/glutamate carrier)

        Milder or Partial Urea Cycle Defects (Late Onset)

        • The severity of urea cycle defects is influenced by:
          • The position of the defective protein in the pathway
          • The severity of the enzymatic deficiency

          Specific Disorders within the Urea Cycle

          • Severe deficiency or total absence of activity of CPS1, OTC, ASS1, ASL, or NAGS causes rapid ammonia accumulation due to the lack of effective alternative clearance mechanisms.
          • Presentation:
            • Typically occurs in the neonatal period due to liver immaturity
            • Infants appear normal at birth but rapidly develop cerebral edema leading to symptoms such as:
              • Lethargy, anorexia
              • Hyperventilation or hypoventilation
              • Hypothermia
              • Seizures, neurological posturing
              • Coma

              Neurological Aspects of UCDs

              • Failure to feed
              • Loss of thermoregulation (hypothermia)
              • Somnolence progressing to lethargy and coma

              Survival and Intellectual Outcomes

              • Early hyperventilation (respiratory alkalosis)
              • Progression to hypoventilation and respiratory arrest as cerebral edema worsens

              Causes and Prevalence of Urea Cycle Disorders (UCDs)

              Login to Read More